{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T02:08:43Z","timestamp":1783908523919,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00210-026-05172-5","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T07:59:15Z","timestamp":1774252755000},"page":"13233-13244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Montelukast impressively mitigates biomarkers of inflammation in non-ST-segment elevation myocardial infarction patients: a randomized, double-blind, placebo-controlled clinical trial"],"prefix":"10.1007","volume":"399","author":[{"given":"Bahram","family":"Shahri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid Reza","family":"Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroush","family":"Fotouhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asal","family":"Yadollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lida","family":"Jarahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser","family":"Bakhoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vafa","family":"Baradaran Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"5172_CR1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00210-024-03330-1","volume":"398","author":"M Ahmadi","year":"2025","unstructured":"Ahmadi M, Askari VR, Shahri B, Mousavi Noghab SM, Jarahi L, Baradaran Rahimi V (2025) Omega-3 fatty acids effectively mitigate high-sensitivity C-reactive protein (hs-CRP) biomarker of inflammation in acute myocardial infarction patients: a randomized, double-blind, placebo-controlled clinical trial. Naunyn Schmiedebergs Arch Pharmacol 398:881\u2013890","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5172_CR2","doi-asserted-by":"publisher","unstructured":"Akg\u00fcl A, Tunca \u00c7, Ta\u015f A, Ayl\u0131 MD\u00a0(2025) Association of serum uric acid and CRP\/albumin ratio with contrast-induced nephropathy in acute myocardial infarction patients. Angiology 33197251376082. https:\/\/doi.org\/10.1177\/00033197251376082","DOI":"10.1177\/00033197251376082"},{"key":"5172_CR3","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1080\/00207454.2020.1769618","volume":"131","author":"E Alizamani","year":"2021","unstructured":"Alizamani E, Ghorbanzadeh B, Naserzadeh R, Mansouri MT (2021) Montelukast, a cysteinyl leukotriene receptor antagonist, exerts local antinociception in animal model of pain through the L-arginine\/nitric oxide\/cyclic GMP\/KATP channel pathway and PPAR\u03b3 receptors. Int J Neurosci 131:1004\u20131011","journal-title":"Int J Neurosci"},{"key":"5172_CR4","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1378\/chest.07-0831","volume":"132","author":"H Allayee","year":"2007","unstructured":"Allayee H, Hartiala J, Lee W, Mehrabian M, Irvin CG, Conti DV, Lima JJ (2007) The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics. Chest 132:868\u2013874","journal-title":"Chest"},{"key":"5172_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ph15091147","author":"BM Alomair","year":"2022","unstructured":"Alomair BM, Al-Kuraishy HM, Al-Gareeb AI, Al-Hamash SM, De Waard M, Sabatier JM, Saad HM, El-Saber Batiha G (2022) Montelukast and acute coronary syndrome: the endowed drug. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph15091147","journal-title":"Pharmaceuticals (Basel)"},{"key":"5172_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aat9453","author":"LG Bankova","year":"2018","unstructured":"Bankova LG, Dwyer DF, Yoshimoto E, Ualiyeva S, McGinty JW, Raff H, von Moltke J, Kanaoka Y, Frank Austen K, Barrett NA (2018) The cysteinyl leukotriene 3 receptor regulates expansion of IL-25-producing airway brush cells leading to type 2 inflammation. Sci Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.aat9453","journal-title":"Sci Immunol"},{"key":"5172_CR7","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.yjmcc.2010.11.013","volume":"50","author":"UM Becher","year":"2011","unstructured":"Becher UM, Ghanem A, Tiyerili V, F\u00fcrst DO, Nickenig G, Mueller CF (2011) Inhibition of leukotriene C4 action reduces oxidative stress and apoptosis in cardiomyocytes and impedes remodeling after myocardial injury. J Mol Cell Cardiol 50:570\u2013577","journal-title":"J Mol Cell Cardiol"},{"key":"5172_CR8","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/jama.2022.0358","volume":"327","author":"DL Bhatt","year":"2022","unstructured":"Bhatt DL, Lopes RD, Harrington RA (2022) Diagnosis and treatment of acute coronary syndromes: a review. JAMA 327:662\u2013675","journal-title":"JAMA"},{"key":"5172_CR9","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/med.21251","volume":"33","author":"V Capra","year":"2013","unstructured":"Capra V, B\u00e4ck M, Barbieri SS, Camera M, Tremoli E, Rovati GE (2013) Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke. Med Res Rev 33:364\u2013438","journal-title":"Med Res Rev"},{"key":"5172_CR10","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1515\/cclm-2013-0423","volume":"51","author":"I Casagranda","year":"2013","unstructured":"Casagranda I, Cavazza M, Clerico A, Galvani M, Ottani F, Zaninotto M, Biasucci LM, Cervellin G, Lenzi T, Lippi G (2013) Proposal for the use in emergency departments of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistent ST-segment elevation. Clin Chem Lab Med 51:1727\u20131737","journal-title":"Clin Chem Lab Med"},{"key":"5172_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1100\/tsw.2011.122","volume":"11","author":"AK Coskun","year":"2011","unstructured":"Coskun AK, Yigiter M, Oral A, Odabasoglu F, Halici Z, Mentes O, Cadirci E, Atalay F, Suleyman H (2011) The effects of Montelukast on antioxidant enzymes and proinflammatory cytokines on the heart, liver, lungs, and kidneys in a rat model of cecal ligation and puncture\u2013induced sepsis. Sci World J 11:1341\u20131356","journal-title":"Sci World J"},{"key":"5172_CR12","doi-asserted-by":"publisher","unstructured":"Crea F, Liuzzo G\u00a0(2016) Anti-inflammatory treatment of acute coronary syndromes: the need for precision medicine. Eur Heart J 37(30):2414\u20136. https:\/\/doi.org\/10.1093\/eurheartj\/ehw207","DOI":"10.1093\/eurheartj\/ehw207"},{"key":"5172_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.intimp.2018.04.042","volume":"61","author":"H Dong","year":"2018","unstructured":"Dong H, Liu F, Ma F, Xu L, Pang L, Li X, Liu B, Wang L (2018) Montelukast inhibits inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. Int Immunopharmacol 61:215\u2013221","journal-title":"Int Immunopharmacol"},{"key":"5172_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.114931","volume":"393","author":"DH El-Kashef","year":"2020","unstructured":"El-Kashef DH, Abdelrahman RS (2020) Montelukast ameliorates Concanavalin A-induced autoimmune hepatitis in mice via inhibiting TNF-\u03b1\/JNK signaling pathway. Toxicol Appl Pharmacol 393:114931","journal-title":"Toxicol Appl Pharmacol"},{"key":"5172_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejphar.2016.03.010","volume":"779","author":"B Ghorbanzadeh","year":"2016","unstructured":"Ghorbanzadeh B, Mansouri MT, Sahraei H, Alboghobeish S (2016) Involvement of opioid receptors in the systemic and peripheral antinociceptive actions of montelukast in the animal models of pain. Eur J Pharmacol 779:38\u201345","journal-title":"Eur J Pharmacol"},{"key":"5172_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104857","volume":"158","author":"R He","year":"2020","unstructured":"He R, Chen Y, Cai Q (2020) The role of the LTB4-BLT1 axis in health and disease. Pharmacol Res 158:104857","journal-title":"Pharmacol Res"},{"key":"5172_CR17","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.biopha.2018.07.033","volume":"106","author":"M Hoxha","year":"2018","unstructured":"Hoxha M, Lewis-Mikhael AM, Bueno-Cavanillas A (2018) Potential role of leukotriene receptor antagonists in reducing cardiovascular and cerbrovascular risk: a systematic review of human clinical trials and in vivo animal studies. Biomed Pharmacother 106:956\u2013965","journal-title":"Biomed Pharmacother"},{"key":"5172_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.611561","volume":"11","author":"M Hoxha","year":"2020","unstructured":"Hoxha M, Tedesco CC, Quaglin S, Malaj V, Pustina L, Capra V, Evans JF, Sala A, Rovati GE (2020) Montelukast use decreases cardiovascular events in asthmatics. Front Pharmacol 11:611561","journal-title":"Front Pharmacol"},{"key":"5172_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.611561","volume":"11","author":"M Hoxha","year":"2021","unstructured":"Hoxha M, Tedesco CC, Quaglin S, Malaj V, Pustina L, Capra V, Evans JF, Sala A, Rovati GE (2021) Montelukast use decreases cardiovascular events in asthmatics. Front Pharmacol 11:611561","journal-title":"Front Pharmacol"},{"key":"5172_CR20","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/jmv.27552","volume":"94","author":"B Kerget","year":"2022","unstructured":"Kerget B, Kerget F, Ayd\u0131n M, Kara\u015fahin \u00d6 (2022) Effect of montelukast therapy on clinical course, pulmonary function, and mortality in patients with COVID-19. J Med Virol 94:1950\u20131958","journal-title":"J Med Virol"},{"key":"5172_CR21","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15513","volume":"10","author":"R Khameneh Bagheri","year":"2022","unstructured":"Khameneh Bagheri R, Najafi MN, Ahmadi M, Saberi M, Maleki M, Baradaran Rahimi V (2022) Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome. Physiol Rep 10:e15513","journal-title":"Physiol Rep"},{"key":"5172_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/0960327115591372","volume":"35","author":"AE Khodir","year":"2016","unstructured":"Khodir AE, Ghoneim HA, Rahim MA, Suddek GM (2016) Montelukast attenuates lipopolysaccharide-induced cardiac injury in rats. Hum Exp Toxicol 35:388\u2013397","journal-title":"Hum Exp Toxicol"},{"key":"5172_CR23","doi-asserted-by":"crossref","unstructured":"Khurshid F, Farooq Z, Ayesha UA, Chaudhry S, Malik K (2023) A comprehensive review of acute coronary syndrome. Ann Innov Med 1 (2):18\u201330","DOI":"10.59652\/aim.v1i2.54"},{"key":"5172_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","volume":"42","author":"PR Lawler","year":"2021","unstructured":"Lawler PR, Bhatt DL, Godoy LC, L\u00fcscher TF, Bonow RO, Verma S, Ridker PM (2021) Targeting cardiovascular inflammation: next steps in clinical translation. Eur Heart J 42:113\u2013131","journal-title":"Eur Heart J"},{"key":"5172_CR25","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.5858\/133.9.1441","volume":"133","author":"G Lippi","year":"2009","unstructured":"Lippi G, Filippozzi L, Salvagno GL, Montagnana M, Franchini M, Guidi GC, Targher G (2009) Increased mean platelet volume in patients with acute coronary syndromes. Arch Pathol Lab Med 133:1441\u20131443","journal-title":"Arch Pathol Lab Med"},{"key":"5172_CR26","first-page":"50","volume":"11","author":"M Mahmudpour","year":"2017","unstructured":"Mahmudpour M, Roozbeh J, Jalali GAR, Pakfetrat M, Zadegan SE, Sagheb MM (2017) Therapeutic effect of montelukast for treatment of uremic pruritus in hemodialysis patients. Iran J Kidney Dis 11:50","journal-title":"Iran J Kidney Dis"},{"key":"5172_CR27","first-page":"50","volume":"11","author":"M Mahmudpour","year":"2017","unstructured":"Mahmudpour M, Roozbeh J, Raiss Jalali GA, Pakfetrat M, Ezzat Zadegan S, Sagheb MM (2017) Therapeutic effect of montelukast for treatment of uremic pruritus in hemodialysis patients. Iran J Kidney Dis 11:50\u201355","journal-title":"Iran J Kidney Dis"},{"key":"5172_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115263","volume":"165","author":"A Malaekeh-Nikouei","year":"2023","unstructured":"Malaekeh-Nikouei A, Shokri-Naei S, Karbasforoushan S, Bahari H, Baradaran Rahimi V, Heidari R, Askari VR (2023) Metformin beyond an anti-diabetic agent: a comprehensive and mechanistic review on its effects against natural and chemical toxins. Biomed Pharmacother 165:115263","journal-title":"Biomed Pharmacother"},{"key":"5172_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53936-x","volume":"14","author":"M Muluhie","year":"2024","unstructured":"Muluhie M, Castiglioni L, Rzemieniec J, Mercuriali B, Gelosa P, Sironi L (2024) Montelukast, an available and safe anti-asthmatic drug, prevents maladaptive remodelling and maintains cardiac functionality following myocardial infarction. Sci Rep 14:3371","journal-title":"Sci Rep"},{"key":"5172_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S (2016) A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7:27","journal-title":"J Basic Clin Pharm"},{"key":"5172_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400240","volume":"357","author":"A Nasimi Shad","year":"2024","unstructured":"Nasimi Shad A, Akhlaghipour I, Babazadeh Baghan A, Askari VR, Baradaran Rahimi V (2024) Caffeic acid and its derivative caffeic acid phenethyl ester as potential therapeutic compounds for cardiovascular diseases: a systematic review. Arch Pharm (Weinheim) 357:e2400240","journal-title":"Arch Pharm (Weinheim)"},{"key":"5172_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/0003319716659583","volume":"68","author":"M Ozturk","year":"2017","unstructured":"Ozturk M, Ask\u0131n L, Ipek E, Demirelli S, Turan OE, Y\u0131ld\u0131r\u0131m E, Ermis E, Kalkan K, Delice O (2017) The role of serum bilirubin levels in predicting troponin positivity in non-ST-segment elevation acute coronary syndrome. Angiology 68:414\u2013418","journal-title":"Angiology"},{"key":"5172_CR33","doi-asserted-by":"crossref","unstructured":"Peters-Golden M, Henderson WR Jr (2007) Leukotrienes. N Engl J Med 357:1841\u20131854","DOI":"10.1056\/NEJMra071371"},{"key":"5172_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2020.100629","volume":"19","author":"E Prescott","year":"2020","unstructured":"Prescott E, Pernow J, Saraste A, \u00c5kerblom A, Anger\u00e5s O, Erlinge D, Grove EL, Hedman M, Jensen LO, Svedlund S, Kjaer M, Lagerstr\u00f6m-Ferm\u00e9r M, Gan LM (2020) Design and rationale of FLAVOUR: a phase IIa efficacy study of the 5-lipoxygenase activating protein antagonist AZD5718 in patients with recent myocardial infarction. Contemp Clin Trials Commun 19:100629","journal-title":"Contemp Clin Trials Commun"},{"key":"5172_CR35","doi-asserted-by":"publisher","first-page":"e771","DOI":"10.1161\/CIR.0000000000001328","volume":"151","author":"SV Rao","year":"2025","unstructured":"Rao SV, O\u2019Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, Baber U, Baker H, Cohen MG, Cruz-Ruiz M, Davis LL, de Lemos JA, DeWald TA, Elgendy IY, Feldman DN, Goyal A, Isiadinso I, Menon V, Morrow DA, Mukherjee D, Platz E, Promes SB, Sandner S, Sandoval Y, Schunder R, Shah B, Stopyra JP, Talbot AW, Taub PR, Williams MS (2025) 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation 151:e771\u2013e862","journal-title":"Circulation"},{"key":"5172_CR36","first-page":"369","volume":"152","author":"TD Schiano","year":"2019","unstructured":"Schiano TD, Florman S, Fiel MI (2019) Recurrent idiopathic liver allograft failure: the role of antibody-mediated rejection. Am J Clin Pathol 152:369\u2013376","journal-title":"Am J Clin Pathol"},{"key":"5172_CR37","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1053\/j.jvca.2019.10.005","volume":"34","author":"M Smit","year":"2020","unstructured":"Smit M, Coetzee AR, Lochner A (2020) The pathophysiology of myocardial ischemia and perioperative myocardial infarction. J Cardiothorac Vasc Anesth 34:2501\u20132512","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"5172_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1046\/j.1365-2222.2001.00969.x","volume":"31","author":"W Storms","year":"2001","unstructured":"Storms W, Michele T, Knorr B, Noonan G, Shapiro G, Zhang J, Shingo S, Reiss T (2001) Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged\u2265 6 years. Clin Exp Allergy 31:77\u201387","journal-title":"Clin Exp Allergy"},{"key":"5172_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2620710","volume":"2022","author":"D Taherzadeh","year":"2022","unstructured":"Taherzadeh D, Baradaran Rahimi V, Amiri H, Ehtiati S, Yahyazadeh R, Hashemy SI, Askari VR (2022) Acetyl-11-keto-\u03b2-boswellic acid (AKBA) prevents lipopolysaccharide-induced inflammation and cytotoxicity on H9C2 cells. Evid Based Complement Alternat Med 2022:2620710","journal-title":"Evid Based Complement Alternat Med"},{"key":"5172_CR40","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1080\/17520363.2025.2590790","volume":"19","author":"A Ta\u015f","year":"2025","unstructured":"Ta\u015f A, Ate\u015f MS, Tunca \u00c7 (2025) Derived neutrophil-to-lymphocyte ratio as a predictor of no-reflow in ST-elevation myocardial infarction. Biomark Med 19:1037\u20131045","journal-title":"Biomark Med"},{"key":"5172_CR41","doi-asserted-by":"publisher","unstructured":"Tunca \u00c7, B\u00fcy\u00fckba\u015f FC, Ta\u015f A, Tan\u0131k VO, Barut\u00e7u S, \u00d6zlek B\u00a0(2025) The Osaka prognostic score predicts all-cause in-hospital mortality in patients with non-ST-elevation myocardial infarction undergoing early percutaneous coronary intervention. Angiology. 33197251370103. https:\/\/doi.org\/10.1177\/00033197251370103","DOI":"10.1177\/00033197251370103"},{"key":"5172_CR42","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/clc.23017","volume":"41","author":"M Vanhaverbeke","year":"2018","unstructured":"Vanhaverbeke M, Veltman D, Pattyn N, De Crem N, Gillijns H, Cornelissen V, Janssens S, Sinnaeve PR (2018) C-reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow-up. Clin Cardiol 41:1201\u20131206","journal-title":"Clin Cardiol"},{"key":"5172_CR43","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4904217","volume":"2020","author":"H Wang","year":"2020","unstructured":"Wang H, Liu Z, Shao J, Lin L, Jiang M, Wang L, Lu X, Zhang H, Chen Y, Zhang R (2020) Immune and inflammation in acute coronary syndrome: molecular mechanisms and therapeutic implications. J Immunol Res 2020:4904217","journal-title":"J Immunol Res"},{"key":"5172_CR44","first-page":"33","volume":"6","author":"X Wang","year":"2023","unstructured":"Wang X, Baskaran L, Chan M, Boisvert W, Hausenloy DJ (2023) Targeting leukotriene biosynthesis to prevent atherosclerotic cardiovascular disease. Condition Med 6:33\u201341","journal-title":"Condition Med"},{"key":"5172_CR45","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2404112","volume":"24","author":"D Yuan","year":"2023","unstructured":"Yuan D, Chu J, Qian J, Lin H, Zhu G, Chen F, Liu X (2023) New concepts on the pathophysiology of acute coronary syndrome. Rev Cardiovasc Med 24:112","journal-title":"Rev Cardiovasc Med"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05172-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05172-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05172-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:44:53Z","timestamp":1783907093000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05172-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5172"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05172-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial was registered under the approval code. IRCT20220516054874N4 at 19\/07\/2022 at\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The Ethics Committee of Mashhad University of Medical Sciences has approved the current investigation (Code of confirmation. IR.MUMS.MEDICAL.REC.1401.187). Moreover,\n                      \n                      was the website where the trial was registered under the approval code. IRCT20220516054874N4 at 19\/07\/2022. Additionally, written informed consent was provided by all members and the study was carried out in accordance with the Declaration of Helsinki and the Mashhad University of Medical Sciences ethics committee approval. Prior to enrollment in the investigation, each participant had been provided with and completed written informed consent forms.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The publication of this study in the journal was approved by all authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}